BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 16085354)

  • 1. Neural regulation of bone and the skeletal effects of serotonin (5-hydroxytryptamine).
    Warden SJ; Bliziotes MM; Wiren KM; Eshleman AJ; Turner CH
    Mol Cell Endocrinol; 2005 Oct; 242(1-2):1-9. PubMed ID: 16085354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypothalamic regulation of bone.
    Driessler F; Baldock PA
    J Mol Endocrinol; 2010 Oct; 45(4):175-81. PubMed ID: 20660619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging neuroskeletal signalling pathways: a review.
    Spencer GJ; Hitchcock IS; Genever PG
    FEBS Lett; 2004 Feb; 559(1-3):6-12. PubMed ID: 14960299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leptin's RIGHT turn to the brain stem.
    Rosen CJ
    Cell Metab; 2009 Oct; 10(4):243-4. PubMed ID: 19808015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skeletal effects of serotonin (5-hydroxytryptamine) transporter inhibition: evidence from in vitro and animal-based studies.
    Warden SJ; Haney EM
    J Musculoskelet Neuronal Interact; 2008; 8(2):121-32. PubMed ID: 18622081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of Semaphorin-3A and its receptors in endochondral ossification: potential role in skeletal development and innervation.
    Gomez C; Burt-Pichat B; Mallein-Gerin F; Merle B; Delmas PD; Skerry TM; Vico L; Malaval L; Chenu C
    Dev Dyn; 2005 Oct; 234(2):393-403. PubMed ID: 16145665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of innervation in the control of bone remodeling.
    Chenu C
    J Musculoskelet Neuronal Interact; 2004 Jun; 4(2):132-4. PubMed ID: 15615111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-HT and bone biology.
    Ducy P
    Curr Opin Pharmacol; 2011 Feb; 11(1):34-8. PubMed ID: 21320797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin 5-hydroxytryptamine2C receptor signaling in hypothalamic proopiomelanocortin neurons: role in energy homeostasis in females.
    Qiu J; Xue C; Bosch MA; Murphy JG; Fan W; Rønnekleiv OK; Kelly MJ
    Mol Pharmacol; 2007 Oct; 72(4):885-96. PubMed ID: 17622577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Convergence between bone and energy homeostases: leptin regulation of bone mass.
    Karsenty G
    Cell Metab; 2006 Nov; 4(5):341-8. PubMed ID: 17084709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sympathetic nervous system and bone adaptive response to its mechanical environment.
    Marenzana M; Chenu C
    J Musculoskelet Neuronal Interact; 2008; 8(2):111-20. PubMed ID: 18622080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What do we know about serotonin?
    Jonnakuty C; Gragnoli C
    J Cell Physiol; 2008 Nov; 217(2):301-6. PubMed ID: 18651566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substance P and its receptors in bone metabolism.
    Liu D; Jiang LS; Dai LY
    Neuropeptides; 2007 Oct; 41(5):271-83. PubMed ID: 17655927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletions of genes encoding calcitonin/alpha-CGRP, amylin and calcitonin receptor have given new and unexpected insights into the function of calcitonin receptors and calcitonin receptor-like receptors in bone.
    Lerner UH
    J Musculoskelet Neuronal Interact; 2006; 6(1):87-95. PubMed ID: 16675892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local serotonergic signaling in mammalian follicles, oocytes and early embryos.
    Dubé F; Amireault P
    Life Sci; 2007 Dec; 81(25-26):1627-37. PubMed ID: 18023821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The emerging role of serotonin (5-hydroxytryptamine) in the skeleton and its mediation of the skeletal effects of low-density lipoprotein receptor-related protein 5 (LRP5).
    Warden SJ; Robling AG; Haney EM; Turner CH; Bliziotes MM
    Bone; 2010 Jan; 46(1):4-12. PubMed ID: 19591966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The roles of dopamine and serotonin, and of their receptors, in regulating sleep and waking.
    Monti JM; Jantos H
    Prog Brain Res; 2008; 172():625-46. PubMed ID: 18772053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of serotonin in failing cardiac ventricle: signalling mechanisms and potential therapeutic implications.
    Levy FO; Qvigstad E; Krobert KA; Skomedal T; Osnes JB
    Neuropharmacology; 2008 Nov; 55(6):1066-71. PubMed ID: 18675829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the neuroendocrine role of serotonin.
    Jørgensen HS
    Dan Med Bull; 2007 Nov; 54(4):266-88. PubMed ID: 18208678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonin modulation of the basal ganglia circuitry: therapeutic implication for Parkinson's disease and other motor disorders.
    Di Matteo V; Pierucci M; Esposito E; Crescimanno G; Benigno A; Di Giovanni G
    Prog Brain Res; 2008; 172():423-63. PubMed ID: 18772045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.